All SEC Filings :: Ligand Pharmaceuticals Incorporated (LGND)

All SEC Filings

Filter Filings:

Date	Form	Description	Docs	XBRL	Pages
02/09/23	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Related Documents EX-99.1			7
02/09/23	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			3
02/09/23	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			4
02/06/23	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			3
01/26/23	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
01/20/23	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			5
01/04/23	4	Statement of changes in beneficial ownership of securities			1
12/30/22	4	Statement of changes in beneficial ownership of securities			1
12/30/22	4	Statement of changes in beneficial ownership of securities			1
12/27/22	4	Statement of changes in beneficial ownership of securities			1